RARE
Ultragenyx Pharmaceutical Inc
Price:  
41.87 
USD
Volume:  
802,954.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Relative Valuation

-681.4%
Upside

As of 2024-05-20, the Relative Valuation of Ultragenyx Pharmaceutical Inc (RARE) is (243.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.87 USD, the upside of Ultragenyx Pharmaceutical Inc based on Relative Valuation is -681.4%.

The range of the Relative Valuation is (212.47) - (223.53) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.8x - 44.5x 36.6x
Forward P/E multiples 28.4x - 30.3x 29.4x
Fair Price (212.47) - (223.53) (243.45)
Upside -607.4% - -633.9% -681.4%
41.87 USD
Stock Price
(243.45) USD
Fair Price

RARE Relative Valuation - Historical P/E Data

Date P/E
2024-05-17 -5.68
2024-05-16 -5.78
2024-05-15 -5.57
2024-05-14 -5.55
2024-05-13 -5.55
2024-05-10 -5.54
2024-05-09 -5.59
2024-05-08 -5.63
2024-05-07 -5.69
2024-05-06 -5.83
2024-05-03 -5.79
2024-05-02 -5.86
2024-05-01 -5.87
2024-04-30 -5.77
2024-04-29 -5.97
2024-04-26 -6.00
2024-04-25 -5.94
2024-04-24 -6.00
2024-04-23 -6.11
2024-04-22 -5.92
2024-04-19 -5.74
2024-04-18 -5.88
2024-04-17 -5.98
2024-04-16 -5.74
2024-04-15 -5.81
2024-04-12 -6.37
2024-04-11 -6.87
2024-04-10 -7.00
2024-04-09 -6.85
2024-04-08 -6.81
2024-04-05 -6.81
2024-04-04 -6.38
2024-04-03 -6.38
2024-04-02 -6.32
2024-04-01 -6.37
2024-03-28 -6.33
2024-03-27 -6.35
2024-03-26 -6.16
2024-03-25 -6.16
2024-03-22 -6.22
2024-03-21 -6.32
2024-03-20 -6.37
2024-03-19 -6.37
2024-03-18 -6.32
2024-03-15 -6.42
2024-03-14 -6.32
2024-03-13 -6.58
2024-03-12 -6.46
2024-03-11 -6.58
2024-03-08 -6.85